COVID-19. Herein, we discuss the use of monoclonal antibodies in addition to vaccination in order to better protect vulnerable people, particularly those with immunosuppression. … Some studies have shown that the strategy of administering a third dose of COVID-19vaccine could benefit some groups of immunocompromisedpatients, such as recipients of solid-organ transplants or patients in hemodialysis [8]. However, this strategy is not effective in all …
Ivan Gentile and Nicola Schiano Moriello discuss the potential of monoclonal antibody prophylaxis against COVID-19 infection in immunocompromised patients.